Literature DB >> 22251851

Growth differences between North American and European children at risk for type 1 diabetes.

Anita M Nucci1, Dorothy J Becker, Suvi M Virtanen, David Cuthbertson, Barney Softness, Celine Huot, Renata Wasikowa, Hans Michael Dosch, Hans K Akerblom, Mikael Knip.   

Abstract

AIM: To evaluate the relationships between early growth and regional variations in type 1 diabetes (T1D) incidence in an international cohort of children with familial and genetic risk for T1D.
METHODS: Anthropometric indices between birth to 5 yr of age were compared among regions and T1D proband in 2160 children participating in the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk study.
RESULTS: Children in Northern Europe had the highest weight z-score between birth to 12 months of age, while those in Southern Europe and U.S.A. had the lowest weight and length/height z-scores at most time points (p < 0.005 to p < 0.001). Few differences in z-score values for weight, height, and body mass index were found by maternal T1D status. Using International Obesity Task Force criteria, the obesity rates generally increased with age and at 5 yr were highest in males in Northern Europe (6.0%) and in females in Canada (12.8%). However, no statistically significance difference was found by geographic region. In Canada, the obesity rate for female children of mothers with and without T1D differed significantly at 4 and 5 yr (6.0 vs. 0.0% and 21.3 vs. 1.9%, respectively; p < 0.0125) but no differences by maternal T1D status were found in other regions.
CONCLUSIONS: There are regional differences in early childhood growth that are consistent with the higher incidence of T1D in Northern Europe and Canada as compared to Southern Europe. Our prospective study from birth will allow evaluation of relationships between growth and the emerging development of autoimmunity and progression to T1D by region in this at-risk population of children.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22251851      PMCID: PMC3335929          DOI: 10.1111/j.1399-5448.2011.00840.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  26 in total

1.  Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study.

Authors:  Christopher C Patterson; Gisela G Dahlquist; Eva Gyürüs; Anders Green; Gyula Soltész
Journal:  Lancet       Date:  2009-05-27       Impact factor: 79.321

2.  Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.

Authors:  E Hyppönen; M G Kenward; S M Virtanen; A Piitulainen; P Virta-Autio; J Tuomilehto; M Knip; H K Akerblom
Journal:  Diabetes Care       Date:  1999-12       Impact factor: 19.112

3.  One- and two-year predictors of excess weight gain among elementary schoolchildren in multiethnic, low-income, inner-city neighborhoods.

Authors:  J O'Loughlin; K Gray-Donald; G Paradis; G Meshefedjian
Journal:  Am J Epidemiol       Date:  2000-10-15       Impact factor: 4.897

Review 4.  The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes.

Authors:  T J Wilkin
Journal:  Diabetologia       Date:  2001-07       Impact factor: 10.122

5.  The relative contributions of birth weight, weight change, and current weight to insulin resistance in contemporary 5-year-olds: the EarlyBird Study.

Authors:  Terence J Wilkin; Bradley S Metcalf; Michael J Murphy; Joanne Kirkby; Alison N Jeffery; Linda D Voss
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

6.  Obesity, increased linear growth, and risk of type 1 diabetes in children.

Authors:  E Hyppönen; S M Virtanen; M G Kenward; M Knip; H K Akerblom
Journal:  Diabetes Care       Date:  2000-12       Impact factor: 19.112

7.  Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes.

Authors:  M Kibirige; B Metcalf; R Renuka; T J Wilkin
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

8.  Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes.

Authors:  Ingrid M Libman; Massimo Pietropaolo; Silva A Arslanian; Ronald E LaPorte; Dorothy J Becker
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

9.  Rapid early growth is associated with increased risk of childhood type 1 diabetes in various European populations.

Authors: 
Journal:  Diabetes Care       Date:  2002-10       Impact factor: 19.112

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  3 in total

1.  Associations of breastfeeding with childhood autoimmunity, allergies, and overweight: The Environmental Determinants of Diabetes in the Young (TEDDY) study.

Authors:  Sandra Hummel; Andreas Weiß; Ezio Bonifacio; Daniel Agardh; Beena Akolkar; Carin A Aronsson; William A Hagopian; Sibylle Koletzko; Jeffrey P Krischer; Åke Lernmark; Kristian Lynch; Jill M Norris; Marian J Rewers; Jin-Xiong She; Jorma Toppari; Ulla Uusitalo; Kendra Vehik; Suvi M Virtanen; Andreas Beyerlein; Anette-G Ziegler
Journal:  Am J Clin Nutr       Date:  2021-07-01       Impact factor: 8.472

2.  Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk.

Authors:  Anita M Nucci; Suvi M Virtanen; David Cuthbertson; Johnny Ludvigsson; Ulle Einberg; Celine Huot; Luis Castano; Bärbel Aschemeier; Dorothy J Becker; Mikael Knip; Jeffrey P Krischer
Journal:  Diabetologia       Date:  2021-01-21       Impact factor: 10.122

3.  Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes.

Authors:  Danièle Pacaud; Anita M Nucci; David Cuthbertson; Dorothy J Becker; Suvi M Virtanen; Johnny Ludvigsson; Jorma Ilonen; Mikael Knip
Journal:  Diabetologia       Date:  2020-10-07       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.